CFT8634: Clinical Trials

1 trial of CFT8634, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow CFT8634: new trials by email Literature Review of CFT8634 trials Research Report on CFT8634

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors
CFT8634 - Synovial Sarcoma, Soft Tissue Sarcoma
Phase 1TerminatedC4 Therapeutics, Inc.492022-03-252024-12-17

Conditions studied

Chondrosarcoma, Extraskeletal Myxoid (1)  ·  Chordoma (1)  ·  Sarcoma (1)  ·  Sarcoma, Synovial (1)

Sponsors

C4 Therapeutics, Inc. (1)

Countries

United States (1)